Top Story

Asthma, COPD devices market expected to reach $34.3 billion by 2020

November 26, 2014

The global asthma and COPD devices market is forecast to reach $34.3 billion by 2020, according to a press release from Allied Market Research.

The figure is based on a compound annual growth rate (CAGR) of 4.5% from 2014 to 2020, the release said. Dry powder inhalers are expected to be “the most lucrative market segment” with a CAGR of 5.3%, according to the release.

In the Journals

Intermittent montelukast for children with wheeze produced no clear benefit

November 25, 2014
Intermittent montelukast in young children with wheeze showed no significant benefit when compared with placebo, according to study results.Researchers conducted a…
In the Journals

Blood lead levels linked with IgE sensitization to dust mites, arthropods

November 25, 2014
A positive relationship existed between blood lead levels and total IgE levels in US adults, with high blood lead levels significantly increasing the risk for IgE…

Stallergenes to develop oral allergy treatment with ActoGeniX

November 24, 2014
Stallergenes has exercised its option to exclusively develop a new class of oral allergy treatments with ActoGeniX, according to a press release.The collaboration, based…
Carla Davis, MD In the Journals

School nurse program increased epinephrine availability to students

November 24, 2014
A training program for school nurses in Houston decreased students’ reactions to food allergies and increased student-specific injectable devices, according to…
More News Headlines »
Meeting News Coverage Video
thumbnail for video 3897883790001

ACAAI president: Upcoming year focuses on empowering 'practicing allergist'

November 18, 2014
ATLANTA — James L. Sublett, MD, FACAAI, recently installed president of the American College of Allergy, Asthma…
More »
morganatic-roan
morganatic-roan